Aspire Biopharma files 1-for-30 reverse stock split

Aspire Biopharma Holdings, Inc.

Filed 1-for-30 reverse stock split of common stock on May 11, 2026.
Fractional shares rounded up; no fractional shares will be issued in the split.
Ticker symbol remains ASBP; new CUSIP number is 738920305.
Effective date set in the Certificate of Amendment filed with Delaware Secretary of State.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.